These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Effect of recombinant interferon alpha 2 on clinical course of first episode genital herpes infection and subsequent recurrences. Mendelson J; Clecner B; Eiley S Genitourin Med; 1986 Apr; 62(2):97-101. PubMed ID: 3087862 [TBL] [Abstract][Full Text] [Related]
3. Therapy of genital herpes with topically applied interferon. Eron LJ; Toy C; Salsitz B; Scheer RR; Wood DL; Nadler PI Antimicrob Agents Chemother; 1987 Jul; 31(7):1137-9. PubMed ID: 3310870 [TBL] [Abstract][Full Text] [Related]
4. Recombinant alpha-2 interferon gel treatment of recurrent herpes genitalis. Lebwohl M; Sacks S; Conant M; Connor J; Douglas JM; Eron L; Marlowe S; Mendelson J; Chen V; Bradstreet P Antiviral Res; 1992 Mar; 17(3):235-43. PubMed ID: 1567188 [TBL] [Abstract][Full Text] [Related]
5. An international, randomized, double-blind, placebo-controlled, study of valacyclovir for the suppression of herpes simplex virus type 2 genital herpes in newly diagnosed patients. Fife KH; Warren TJ; Justus SE; Heitman CK; Sex Transm Dis; 2008 Jul; 35(7):668-73. PubMed ID: 18461016 [TBL] [Abstract][Full Text] [Related]
6. [Beta-interferon for labial and genital herpes virus infection]. Glezerman M; Lunenfeld E; Doerner T; Cohen V; Sarov I; Revel M Harefuah; 1989 Jan; 116(2):88-90. PubMed ID: 2651244 [TBL] [Abstract][Full Text] [Related]
7. Topical alpha-interferon in recurrent genital herpes simplex infection. A double-blind, placebo-controlled clinical trial. Shupack J; Stiller M; Knobler E; Ackerman C; Jondreau L; Kenny C Dermatologica; 1990; 181(2):134-8. PubMed ID: 2242782 [TBL] [Abstract][Full Text] [Related]
8. Valaciclovir for the suppression of recurrent genital HSV infection: a placebo controlled study of once daily therapy. International Valaciclovir HSV Study Group. Patel R; Bodsworth NJ; Woolley P; Peters B; Vejlsgaard G; Saari S; Gibb A; Robinson J Genitourin Med; 1997 Apr; 73(2):105-9. PubMed ID: 9215091 [TBL] [Abstract][Full Text] [Related]
9. Interferon in the prevention of genital herpes recurrence. Eron LJ; Harvey L; Toy C; Santomauro D Antimicrob Agents Chemother; 1986 Oct; 30(4):608-10. PubMed ID: 3789694 [TBL] [Abstract][Full Text] [Related]
10. Human leukocyte interferon-alpha in cream for the treatment of genital herpes in Asian males. A placebo-controlled, double-blind study. Syed TA; Cheema KM; Kahlon BM; Kahlon RC; Khayyami M; Kahlon AM; Kahlon MM Dermatology; 1995; 191(1):32-5. PubMed ID: 8589479 [TBL] [Abstract][Full Text] [Related]
11. Placebo-controlled trial of topical interferon in labial and genital herpes. Glezerman M; Lunenfeld E; Cohen V; Sarov I; Movshovitz M; Doerner T; Shoham J; Revel M Lancet; 1988 Jan; 1(8578):150-2. PubMed ID: 2892991 [TBL] [Abstract][Full Text] [Related]
12. Effect of valacyclovir on viral shedding in immunocompetent patients with recurrent herpes simplex virus 2 genital herpes: a US-based randomized, double-blind, placebo-controlled clinical trial. Fife KH; Warren TJ; Ferrera RD; Young DG; Justus SE; Heitman CK; Burroughs SM Mayo Clin Proc; 2006 Oct; 81(10):1321-7. PubMed ID: 17036557 [TBL] [Abstract][Full Text] [Related]
13. Randomized, double-blind, placebo-controlled, patient-initiated study of topical high- and low-dose interferon-alpha with nonoxynol-9 in the treatment of recurrent genital herpes. Sacks SL; Varner TL; Davies KS; Rekart ML; Stiver HG; DeLong ER; Sellers PW J Infect Dis; 1990 Apr; 161(4):692-8. PubMed ID: 2156945 [TBL] [Abstract][Full Text] [Related]
14. Human leukocyte interferon-alpha in a hydrophilic cream versus in a gel for the treatment of genital herpes in males: a placebo-controlled, double-blind, comparative study. Syed TA; Ahmadpour OA; Ahmad SA; Ahmad SH J Dermatol; 1997 Sep; 24(9):564-8. PubMed ID: 9350101 [TBL] [Abstract][Full Text] [Related]
15. Comparison of intramuscular recombinant alpha interferon (rIFN-2A) with topical acyclovir for the treatment of first-episode herpes genitalis and prevention of recurrences. Levin MJ; Judson FN; Eron L; Bryson YJ; Corey L; Murray M; Scheer RR Antimicrob Agents Chemother; 1989 May; 33(5):649-52. PubMed ID: 2751279 [TBL] [Abstract][Full Text] [Related]
16. Valaciclovir: a review of its long term utility in the management of genital herpes simplex virus and cytomegalovirus infections. Ormrod D; Scott LJ; Perry CM Drugs; 2000 Apr; 59(4):839-63. PubMed ID: 10804039 [TBL] [Abstract][Full Text] [Related]
17. Efficacy of interferon and placebo in the treatment of recurrent genital herpes: a double-blind trial. Lassus A; Bergelin I; Paloranta A; Rinne E; Eskelinen A; Säilä K Sex Transm Dis; 1987; 14(4):185-90. PubMed ID: 3438782 [TBL] [Abstract][Full Text] [Related]
18. Treatment of first episodes of genital herpes simplex virus infection with oral acyclovir. A randomized double-blind controlled trial in normal subjects. Bryson YJ; Dillon M; Lovett M; Acuna G; Taylor S; Cherry JD; Johnson BL; Wiesmeier E; Growdon W; Creagh-Kirk T; Keeney R N Engl J Med; 1983 Apr; 308(16):916-21. PubMed ID: 6339923 [TBL] [Abstract][Full Text] [Related]
19. Topical interferon cream for the treatment of herpes genitalis: a double-blind controlled trial. Batcheler LM; Bonham DG; Collins R; Liddell HS Aust N Z J Obstet Gynaecol; 1986 Aug; 26(3):239-41. PubMed ID: 3028362 [TBL] [Abstract][Full Text] [Related]
20. A trial of topical acyclovir in genital herpes simplex virus infections. Corey L; Nahmias AJ; Guinan ME; Benedetti JK; Critchlow CW; Holmes KK N Engl J Med; 1982 Jun; 306(22):1313-9. PubMed ID: 6280052 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]